Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 9/20 | 0.42 |
| ▸ | BRAF | P15056 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | UBE2M | P61081 | 1/20 | 0.39 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24516620 | 0.81 | AR (0.46) | ARGRM4KDRBRAFKMT2A | |
| SCHEMBL24516621 | 0.81 | AR (0.46) | ARGRM4KDRBRAFKMT2A | |
| SCHEMBL26613003 | 0.80 | AR (0.48) | ARGRM4KDRBRAFNPY5R | |
| SCHEMBL24515714 | 0.80 | AR (0.51) | ARGRM4KDRBRAFKMT2A | |
| SCHEMBL31627181 | 0.80 | L3MBTL1 (0.56) | ARGRM4KDRBRAFKMT2A | |
| SCHEMBL31135568 | 0.80 | L3MBTL1 (0.56) | ARGRM4KDRBRAFKMT2A | |
| Hydrochloric Acid SCHEMBL26613248 | 0.80 | AR (0.45) | ARGRM4KDRBRAFKMT2A | |
| Bromide SCHEMBL30638609 | 0.79 | AR (0.47) | ARGRM4KDRBRAFNPY5R | |
| SCHEMBL24515710 | 0.78 | AR (0.46) | ARGRM4KDRBRAFKMT2A | |
| SCHEMBL26696301 | 0.78 | AR (0.46) | ARGRM4KDRBRAFKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118434712-A | Bicyclo [3.2.0] heptane bis (amide) RXFP1 agonists | 百时美施贵宝公司 | 2024-08-02 | — | — | CN | disclosed |